“Biotechnology has risen to the top of national agendas in the post-pandemic era. PwC forecasts that mergers and acquisitions in the U.S. pharmaceuticals and life sciences sector alone could reach US$225 billion to US$275 billion in 2023. Biotechnology harnesses cellular and biological processes to develop products and technologies used in our everyday lives. The sector has grown globally over the past couple of decades owing to its potential to transform human health and its wide applicability across sectors, including health, agriculture, and chemicals. The green agenda has also brought to the fore applications such as resource recovery, recycling, and hazardous waste disposal.” 

Accelerating Saudi Arabia’s biotechnology sector [Strategy&/PwC]